TP0586532, a non-hydroxamate LpxC inhibitor, reduces LPS release and IL-6 production both in vitro and in vivo
Kiyoko Fujita, Iichiro Takata, Ippei Yoshida, Hajime Takashima, Hiroyuki Sugiyama
Topics & Concepts
LipopolysaccharideIn vivoMeropenemMicrobiologyPharmacologyCiprofloxacinIn vitroLipid AChemistryBiologyAntibioticsImmunologyBiochemistryAntibiotic resistanceBiotechnologyAntibiotic Resistance in BacteriaImmune Response and InflammationAntibiotics Pharmacokinetics and Efficacy